GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Beijing Strong Biotechnologies Inc (SZSE:300406) » Definitions » Cyclically Adjusted FCF per Share

Beijing Strong Biotechnologies (SZSE:300406) Cyclically Adjusted FCF per Share : ¥0.44 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Beijing Strong Biotechnologies Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Beijing Strong Biotechnologies's adjusted free cash flow per share for the three months ended in Mar. 2024 was ¥-0.038. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.44 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Beijing Strong Biotechnologies's average Cyclically Adjusted FCF Growth Rate was 10.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-06-08), Beijing Strong Biotechnologies's current stock price is ¥17.31. Beijing Strong Biotechnologies's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥0.44. Beijing Strong Biotechnologies's Cyclically Adjusted Price-to-FCF of today is 39.34.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Beijing Strong Biotechnologies was 58.50. The lowest was 37.80. And the median was 45.52.


Beijing Strong Biotechnologies Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Beijing Strong Biotechnologies's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Strong Biotechnologies Cyclically Adjusted FCF per Share Chart

Beijing Strong Biotechnologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.41 0.44

Beijing Strong Biotechnologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.41 0.43 0.44 0.44

Competitive Comparison of Beijing Strong Biotechnologies's Cyclically Adjusted FCF per Share

For the Diagnostics & Research subindustry, Beijing Strong Biotechnologies's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Strong Biotechnologies's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Beijing Strong Biotechnologies's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Beijing Strong Biotechnologies's Cyclically Adjusted Price-to-FCF falls into.



Beijing Strong Biotechnologies Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Beijing Strong Biotechnologies's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.038/115.2271*115.2271
=-0.038

Current CPI (Mar. 2024) = 115.2271.

Beijing Strong Biotechnologies Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.144 98.200 0.169
201409 0.185 98.900 0.216
201412 0.272 99.000 0.317
201503 0.018 99.900 0.021
201506 0.184 99.500 0.213
201509 -0.038 100.500 -0.044
201512 0.176 100.600 0.202
201603 0.007 102.200 0.008
201606 0.069 101.400 0.078
201609 0.118 102.400 0.133
201612 0.129 102.600 0.145
201703 0.042 103.200 0.047
201706 0.085 103.100 0.095
201709 0.073 104.100 0.081
201712 0.179 104.500 0.197
201803 0.025 105.300 0.027
201806 0.076 104.900 0.083
201809 0.105 106.600 0.113
201812 0.124 106.500 0.134
201903 -0.017 107.700 -0.018
201906 0.091 107.700 0.097
201909 0.030 109.800 0.031
201912 0.150 111.200 0.155
202003 -0.069 112.300 -0.071
202006 0.014 110.400 0.015
202009 0.053 111.700 0.055
202012 0.168 111.500 0.174
202103 -0.039 112.662 -0.040
202106 0.154 111.769 0.159
202109 0.135 112.215 0.139
202112 0.221 113.108 0.225
202203 -0.034 114.335 -0.034
202206 0.192 114.558 0.193
202209 0.150 115.339 0.150
202212 0.207 115.116 0.207
202303 -0.035 115.116 -0.035
202306 0.186 114.558 0.187
202309 0.284 115.339 0.284
202312 0.293 114.781 0.294
202403 -0.038 115.227 -0.038

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Beijing Strong Biotechnologies  (SZSE:300406) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Beijing Strong Biotechnologies's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=17.31/0.44
=39.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Beijing Strong Biotechnologies was 58.50. The lowest was 37.80. And the median was 45.52.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Beijing Strong Biotechnologies Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Beijing Strong Biotechnologies's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Strong Biotechnologies (SZSE:300406) Business Description

Traded in Other Exchanges
N/A
Address
No. 15 Hua Yuan Dong Lu, 5th Floor, Kuang Yi Building, Haidian District, Beijing, CHN, 100191
Beijing Strong Biotechnologies Inc is a China-based provider of in-vitro (IVD) diagnostics products and service. The company is engaged in the research, development, production, and sale of IVD products. It also provides diversified clinical diagnosis solutions to customers. Its products include clinical biochemistry testing, coagulation testing, blood typing, serology and automated blood grouping analyzer. The firm has established a clinical biochemistry platform of the enzymatic method (including enzymatic cycling method), immunoturbidimetric method, and latex immunoturbidimetric method.
Executives
Shuang He Executives
Luo Ai Ping Director
Directors, executives
Liu Wei Executives
Zhou Ming Executives
Zhuang Xian Min Directors, executives
Zhang Yi Executives
Liu Xi Directors, executives
Sun Xiao Lin Director
Yu Jian Ping Executives

Beijing Strong Biotechnologies (SZSE:300406) Headlines

No Headlines